Complete Filing Data
Canton Strategic Holdings, Inc. reported Stockholders Equity of $397.93 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Canton Strategic Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$35.9M | -$12.2M | -$9.3M | -$8.5M | -$2.2M | -$2.4M |
| Research And Development Expense | $3.1M | $6.4M | $3.6M | $2.3M | $1.8M | $847.3K |
| Operating Income Loss | -$20.1M | -$12.4M | -$9.5M | -$6.9M | -$3.2M | -$1.8M |
| Operating Expenses | $20.1M | $12.4M | $9.5M | $6.9M | $3.2M | $1.8M |
| General And Administrative Expense | $17.0M | $6.0M | $5.9M | $4.6M | $1.4M | $671.9K |
| Nonoperating Income Expense | -$22.0M | $236.2K | $136.1K | -$1.6M | $1.0M | -$609.0K |
| Interest Expense | $16.5K | $1.6M | $831.3K | $246.5K | ||
| Interest Expense Nonoperating | $28.3K | $13.7K | $16.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$2.1M | -$1.9M | -$2.5M | -$3.8M | -$2.3M | -$2.3M | -$1.8M | -$2.3M | -$2.7M | -$2.1M | -$1.6M | -$2.9M | -$853.4K | -$1.6M | -$2.3M |
| Research And Development Expense | $277.8K | $546.2K | $594.1K | $2.3M | $999.6K | $1.0M | $488.2K | $1.0M | $1.0M | $831.8K | $455.5K | $307.8K | $313.1K | $674.8K | $895.9K |
| Operating Income Loss | -$2.1M | -$1.9M | -$2.5M | -$3.9M | -$2.4M | -$2.3M | -$1.8M | -$2.4M | -$2.7M | -$2.1M | -$1.6M | -$1.4M | -$541.1K | -$1.1M | -$1.5M |
| Operating Expenses | $2.1M | $1.9M | $2.5M | $3.9M | $2.4M | $2.3M | $1.8M | $2.4M | $2.7M | $2.1M | $1.6M | $1.4M | $541.1K | $1.1M | $1.5M |
| General And Administrative Expense | $1.8M | $1.3M | $2.0M | $1.6M | $1.4M | $1.3M | $1.4M | $1.3M | $1.7M | $1.3M | $1.2M | $1.0M | $228.0K | $423.0K | $571.7K |
| Nonoperating Income Expense | -$8.3K | -$4.0K | $5.0K | $69.7K | $48.4K | $91.2K | $25.0K | $27.7K | $26.1K | -$1.6M | -$312.3K | -$458.4K | -$782.5K | ||
| Interest Expense | $4.7K | $3.5K | $6.5K | $6.1K | $1.6M | $235.8K | $188.9K | $148.2K | |||||||
| Interest Expense Nonoperating | $9.6K | $6.2K | $8.5K | $3.0K | $5.2K | $4.7K | $3.5K | $6.5K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $397.9M | $1.3M | $9.1M | $5.5M | -$4.7M | -$3.7M | -$1.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $3.6M | $10.9M | $6.5M | $4.4K | $191.9K | $38.3K | |
| Retained Earnings Accumulated Deficit | -$72.8M | -$36.9M | -$24.7M | -$15.4M | -$6.9M | -$4.7M | |
| Prepaid Expense And Other Assets Current | $353.3K | $45.3K | $11.0K | $178.1K | $70.7K | $102.9K | |
| Liabilities Current | $3.3M | $2.4M | $1.8M | $1.1M | $4.5M | $2.7M | |
| Liabilities And Stockholders Equity | $519.1M | $3.7M | $10.9M | $6.7M | $621.7K | $294.8K | |
| Liabilities | $121.2M | $2.4M | $1.8M | $1.1M | $5.3M | $4.0M | |
| Common Stock Value | $3.7K | $198.00 | $89.00 | $46.00 | $636.00 | $636.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $13.5M | -$7.4M | $4.4M | $6.5M | -$187.5K | $153.6K | |
| Assets Current | $17.4M | $3.7M | $10.9M | $6.7M | $621.7K | $294.8K | |
| Assets | $519.1M | $3.7M | $10.9M | $6.7M | $621.7K | $294.8K | |
| Accounts Payable Current | $1.1M | $1.1M | $908.6K | $954.5K | $1.5M | $514.8K | |
| Treasury Stock Value | $70.0K | $70.0K | $70.0K | $70.0K | |||
| Accrued Liabilities Current | $2.2M | $1.3M | $906.5K | $190.5K | $318.2K | $48.8K | |
| Repayment Of Insurance Premium Financing Liability | $285.2K | $394.0K | $716.8K | $917.5K | |||
| Treasury Stock Common Shares | 246.00 | 246.00 | 246.00 | 3.6K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $17.0M | $3.6M | $10.9M | ||||
| Cash | $6.5M | ||||||
| Amortization Of Debt Discount Premium | $1.6M | $666.6K | $145.4K | ||||
| Cash And Cash Equivalents At Carrying Value | $6.5M | ||||||
| Interest Payable Current | $190.5K | $179.6K | $73.1K | ||||
| Deferred Offering Costs | $0.00 | $117.0K | $546.7K | ||||
| Treasury Stock Shares | 90.8K | 0.00 | |||||
| Stock Issued During Period Value Private Investments In Public Equity Offering Net Of Issuance Costs | $3.3M | $3.6M | |||||
| Repayments Of Notes Payable | $221.9K | $139.6K | |||||
| Treasury Stock Value Acquired Cost Method | $70.0K | ||||||
| Insurance Premium Financing Liability | |||||||
| Debt Conversion Converted Instrument Amount1 | $3.7M | ||||||
| Convertible Notes Payable Current | $1.4M | $563.4K | |||||
| Convertible Long Term Notes Payable | $772.9K | $1.3M | |||||
| Unpaid Deferred Offering Costs | $367.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $6.2M | $367.4K | -$814.7K | $3.0M | $6.7M | $7.0M | $1.8M | $3.1M | $3.2M | $7.1M | $9.0M | $10.3M | -$7.1M | -$6.3M | -$5.3M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $8.4M | $2.7M | $3.9M | $3.6M | $7.6M | $9.5M | $11.1M | $45.1K | $29.3K | $22.5K | ||||||||
| Retained Earnings Accumulated Deficit | -$43.4M | -$41.3M | -$39.4M | -$33.1M | -$29.3M | -$27.0M | -$22.2M | -$20.4M | -$18.1M | -$13.6M | -$11.5M | -$9.9M | ||||||
| Prepaid Expense And Other Assets Current | $89.0K | $196.0K | $468.4K | $477.0K | $301.6K | $460.0K | $412.9K | $695.4K | $1.1M | $236.0K | $301.4K | $233.2K | ||||||
| Liabilities Current | $1.5M | $2.2M | $2.5M | $2.2M | $1.6M | $1.8M | $1.4M | $1.5M | $1.5M | $716.7K | $745.5K | $1.0M | ||||||
| Liabilities And Stockholders Equity | $7.7M | $2.5M | $1.7M | $5.3M | $8.3M | $8.9M | $3.2M | $4.6M | $4.7M | $7.8M | $9.8M | $11.4M | ||||||
| Liabilities | $1.5M | $2.2M | $2.5M | $2.2M | $1.6M | $1.8M | $1.4M | $1.5M | $1.5M | $716.7K | $745.5K | $1.0M | ||||||
| Common Stock Value | $721.00 | $422.00 | $211.00 | $129.00 | $111.00 | $1.2K | $1.8K | $1.7K | $1.2K | $1.2K | $1.2K | $1.1K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.5M | -$2.5M | -$2.9M | $11.1M | -$169.3K | |||||||||||||
| Assets Current | $7.7M | $2.5M | $1.7M | $5.3M | $8.3M | $8.9M | $3.2M | $4.6M | $4.7M | $7.8M | $9.8M | $11.4M | ||||||
| Assets | $7.7M | $2.5M | $1.7M | $5.3M | $8.3M | $8.9M | $3.2M | $4.6M | $4.7M | $7.8M | $9.8M | $11.4M | ||||||
| Accounts Payable Current | $659.3K | $770.6K | $838.2K | $783.8K | $784.0K | $993.2K | $1.1M | $1.1M | $719.0K | $536.8K | $559.5K | $597.5K | ||||||
| Treasury Stock Value | $70.0K | $70.0K | $70.0K | $70.0K | $70.0K | $70.0K | $70.0K | $70.0K | $70.0K | $62.1K | $24.7K | |||||||
| Accrued Liabilities Current | $689.8K | $1.1M | $1.1M | $1.4M | $579.5K | $179.9K | $185.9K | $218.9K | ||||||||||
| Repayment Of Insurance Premium Financing Liability | $60.3K | $76.8K | $156.9K | $181.4K | ||||||||||||||
| Treasury Stock Common Shares | 246.00 | 246.00 | 246.00 | 246.00 | 246.00 | 3.6K | 90.8K | 90.8K | 90.8K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.6M | $2.2M | $1.1M | $4.8M | $7.9M | $8.4M | $2.7M | $3.9M | $6.5M | |||||||||
| Cash | $7.6M | $2.2M | $3.6M | $4.8M | $7.9M | $8.4M | $10.9M | $2.7M | $3.9M | $3.6M | ||||||||
| Amortization Of Debt Discount Premium | $1.6M | $114.1K | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $7.6M | $2.2M | $3.6M | $4.8M | $7.9M | $8.4M | $10.9M | $2.7M | $3.9M | $3.6M | ||||||||
| Interest Payable Current | $527.5K | $906.5K | $190.3K | $67.9K | $242.2K | |||||||||||||
| Deferred Offering Costs | $92.2K | $117.0K | $60.0K | $65.0K | $81.7K | |||||||||||||
| Treasury Stock Shares | 75.1K | 30.0K | ||||||||||||||||
| Stock Issued During Period Value Private Investments In Public Equity Offering Net Of Issuance Costs | $1.1M | $2.3M | $1.8M | |||||||||||||||
| Repayments Of Notes Payable | $43.0K | $139.6K | ||||||||||||||||
| Treasury Stock Value Acquired Cost Method | $37.4K | $24.7K | ||||||||||||||||
| Insurance Premium Financing Liability | $34.4K | $84.5K | $248.6K | $80.8K | $200.0K | $317.1K | $81.0K | $322.0K | $559.9K | |||||||||
| Debt Conversion Converted Instrument Amount1 | $3.7M | |||||||||||||||||
| Convertible Notes Payable Current | ||||||||||||||||||
| Convertible Long Term Notes Payable | ||||||||||||||||||
| Unpaid Deferred Offering Costs | $45.1K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share-Based Compensation * | $2.9M | $710.3K | $831.9K | $800.7K | $1.2M | $234.6K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $2.9M | $710.3K | $831.9K | $800.7K | $1.2M | $234.6K |
| Net Cash Provided By Used In Operating Activities | -$16.1M | -$10.9M | -$7.3M | -$6.6M | -$1.1M | -$1.1M |
| Net Cash Provided By Used In Financing Activities | $107.2M | $3.5M | $11.7M | $13.1M | $898.7K | $1.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $308.1K | $34.2K | -$167.1K | $107.4K | -$32.3K | $100.3K |
| Increase Decrease In Accrued Liabilities | $1.1M | $417.8K | $716.0K | -$127.8K | $269.4K | |
| Increase Decrease In Accounts Payable Trade | $222.5K | $181.1K | -$45.9K | -$141.2K | $580.8K | |
| Proceeds From Insurance Premium Financing Liability | $285.2K | $394.0K | $716.8K | $917.5K | ||
| Proceeds From Issuance Of Common Stock | $99.4M | $12.2M | $13.6M | |||
| Payments Of Stock Issuance Costs | $568.7K | $1.9M | $2.1M | |||
| Increase Decrease In Interest Payable | $7.2K | $164.6K | ||||
| Proceeds From Stock Options Exercised | $166.3K | $24.4K | ||||
| Proceeds From Issuance Of Private Placement | $3.7M | $4.1M | ||||
| Increase Decrease In Due To Related Parties | -$200.0K | |||||
| Proceeds From Convertible Debt | $1.1M | $1.2M | ||||
| Net Cash Provided By Used In Investing Activities | -$77.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $219.2K | $153.6K | $345.4K | $19.4K | $674.1K | ||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $527.0K | $559.4K | $219.2K | $191.9K | $153.6K | $153.6K | $158.0K | $158.0K | $345.4K | $240.8K | $338.6K | $19.4K | $4.4K | $554.0K | $674.1K |
| Net Cash Provided By Used In Operating Activities | -$2.7M | -$2.8M | -$3.5M | -$2.7M | -$492.4K | ||||||||||
| Net Cash Provided By Used In Financing Activities | $205.6K | $317.1K | $523.4K | $13.8M | $323.0K | ||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $423.1K | $449.0K | $893.0K | $898.6K | -$42.6K | ||||||||||
| Increase Decrease In Accrued Liabilities | -$6.4K | -$378.9K | $51.8K | -$99.3K | $199.4K | ||||||||||
| Increase Decrease In Accounts Payable Trade | $63.0K | $84.7K | -$280.6K | -$498.2K | |||||||||||
| Proceeds From Insurance Premium Financing Liability | $308.9K | $394.0K | $716.8K | $917.5K | |||||||||||
| Proceeds From Issuance Of Common Stock | $13.6M | ||||||||||||||
| Payments Of Stock Issuance Costs | $202.2K | $240.0K | $268.3K | $602.8K | $521.3K | ||||||||||
| Increase Decrease In Interest Payable | $7.2K | ||||||||||||||
| Proceeds From Stock Options Exercised | |||||||||||||||
| Proceeds From Issuance Of Private Placement | |||||||||||||||
| Increase Decrease In Due To Related Parties | |||||||||||||||
| Proceeds From Convertible Debt | $323.0K | ||||||||||||||
| Net Cash Provided By Used In Investing Activities |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.12 | -$9.41 | -$107.02 | -$18.72 | -$0.35 | -$0.38 | |
| Common Stock Shares Authorized | 1.00B | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M |
| Weighted Average Number Of Shares Outstanding Basic | 32.0M | 1.3M | 87.1K | 452.7K | 6.4M | ||
| Earnings Per Share Basic | $-1.12 | $-9.41 | $-107.02 | $-18.72 | $-0.35 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 37.1M | 2.0M | 884.5K | 460.6K | 6.4M | 6.4M | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Common Stock Shares Issued | 37.1M | 2.0M | 884.7K | 464.2K | 6.4M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Diluted Shares Outstanding | 32.0M | 1.3M | 87.1K | 452.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.34 | -$0.64 | -$0.99 | -$2.45 | -$2.42 | -$2.55 | -$39.42 | -$52.06 | -$5.84 | -$0.18 | $0.14 | ||||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | |||
| Weighted Average Number Of Shares Outstanding Basic | 6.2M | 2.9M | 2.6M | 1.5M | 962.1K | 885.7K | 46.2K | 44.9K | 460.6K | 11.5M | 11.6M | 10.6M | 6.4M | 6.4M | 6.4M |
| Earnings Per Share Basic | $-0.34 | $-0.64 | $-0.99 | $-2.45 | $-2.42 | $-2.55 | $-39.42 | $-52.06 | $-5.84 | $-0.18 | $0.14 | $-0.28 | $-0.13 | $-0.24 | $-0.35 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 7.2M | 4.2M | 2.1M | 1.3M | 1.1M | 11.8M | 17.5M | 16.8M | 11.5M | 11.5M | 11.6M | 11.4M | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Common Stock Shares Issued | 7.2M | 4.2M | 2.1M | 1.3M | 1.1M | 11.8M | 17.6M | 16.9M | 11.6M | 11.6M | 11.6M | 11.4M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 6.2M | 2.9M | 2.6M | 1.5M | 962.1K | 885.7K | 46.2K | 44.9K | 460.6K | 11.5M | 11.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Additional Paid In Capital | $470.8M | $38.3M | $33.9M | $21.0M | $2.2M | $986.4K |
| Interest Income Other | $41.4K | $249.9K | $152.6K | |||
| Payment Of Financing And Stock Issuance Costs | $793.0K | $661.7K | $519.2K | $521.3K | $179.3K | |
| Issuance Of Stock And Warrants For Services Or Claims | $8.3K | $20.6K | $350.0K | $100.0K | ||
| Stock Issued During Period Value New Issues | $5.4M | $73.2K | $11.7M | $12.9M | ||
| Stock Issued During Period Value Issued For Services | $20.6K | $350.0K | $100.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $166.3K | $24.4K | ||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $4.9M | |||||
| Due To Related Parties Current | $200.0K | $200.0K | ||||
| Notes Issued1 | $314.5K | $186.9K | ||||
| Interest Paid Net | $28.3K | $13.7K | $16.5K | $22.2K | ||
| Notes Reduction | $980.2K | |||||
| Stock Issued During Period Shares Stock Options Exercised | 125.0K | 9.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $49.6M | $41.7M | $38.7M | $36.2M | $36.0M | $34.1M | $24.1M | $23.5M | $21.3M | $20.8M | $20.6M | $20.2M |
| Interest Income Other | $1.4K | $2.2K | $13.4K | $72.7K | $53.6K | $95.9K | $28.5K | $34.2K | $32.2K | |||
| Payment Of Financing And Stock Issuance Costs | $793.0K | $36.6K | $521.3K | |||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $20.6K | $100.0K | ||||||||||
| Stock Issued During Period Value New Issues | -$72.5K | $2.0M | $12.9M | |||||||||
| Stock Issued During Period Value Issued For Services | $20.6K | $350.0K | $100.0K | |||||||||
| Stock Issued During Period Value Stock Options Exercised | $24.4K | |||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $4.9M | |||||||||||
| Due To Related Parties Current | $200.0K | |||||||||||
| Notes Issued1 | $186.9K | |||||||||||
| Interest Paid Net | $8.5K | $4.7K | ||||||||||
| Notes Reduction | $980.2K | |||||||||||
| Stock Issued During Period Shares Stock Options Exercised |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.